000 01468 a2200433 4500
005 20250518091541.0
264 0 _c20210618
008 202106s 0 0 eng d
022 _a1549-490X
024 7 _a10.1634/theoncologist.2019-0578
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMartini, Dylan J
245 0 0 _aNovel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.
_h[electronic resource]
260 _bThe oncologist
_c03 2020
300 _ae484-e491 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aCarcinoma, Renal Cell
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aImmune Checkpoint Inhibitors
650 0 4 _aKidney Neoplasms
_xdrug therapy
650 0 4 _aMale
650 0 4 _aProspective Studies
650 0 4 _aRetrospective Studies
650 0 4 _aRisk Factors
700 1 _aLiu, Yuan
700 1 _aShabto, Julie M
700 1 _aCarthon, Bradley C
700 1 _aHitron, Emilie Elise
700 1 _aRussler, Greta Anne
700 1 _aCaulfield, Sarah
700 1 _aKissick, Haydn T
700 1 _aHarris, Wayne B
700 1 _aKucuk, Omer
700 1 _aMaster, Viraj A
700 1 _aBilen, Mehmet Asim
773 0 _tThe oncologist
_gvol. 25
_gno. 3
_gp. e484-e491
856 4 0 _uhttps://doi.org/10.1634/theoncologist.2019-0578
_zAvailable from publisher's website
999 _c30733173
_d30733173